Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4651602015 | Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4651603013 | Product containing lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Is a | Product containing lidocaine and metronidazole and sucralfate (medicinal product) | true | Inferred relationship | Some | ||
| Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Is a | Product containing metronidazole in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Is a | Lidocaine-containing product in cutaneous dose form | true | Inferred relationship | Some | ||
| Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Some | ||
| Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some | ||
| Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Has active ingredient | Metronidazole (substance) | true | Inferred relationship | Some | 1 | |
| Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Has active ingredient | Sucralfate (substance) | true | Inferred relationship | Some | 2 | |
| Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Has active ingredient | Lidocaine (substance) | true | Inferred relationship | Some | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) | Is a | True | Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Inferred relationship | Some | |
| Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream | Is a | True | Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR